Nanobacteria: Fact or Fiction? Characteristics,Detection,and Medical Importance of Novel Self-Replicating,Calcifying Nanoparticles

Sarikaya M . Biomimetics: materials fabrication through biology. PNAS 1999;96:14183–5.

Tadic D , Peters F , Epple M . Continuous synthesis of amorphous carbonated apatites. Biomaterials 2002;23:2553–9.

Inayat-Hussain SH , Rajab NF , Roslie H , . Cell death induced by hydroxyapatite on L929 fibroblast cells. Med J Malaysia 2004;59:176–7.

Barroug A , Kuhn LT , Gerstenfeld LC , Glimcher MJ . Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release. J Orthop Res 2004;22:703–8.

Rauschmann MA , Wichelhaus TA , Stirnal V , . Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005;26:2677–84.

Albiar E , Holds JB . Hydroxyapatite orbital implants: indications for use and nursing considerations. J Ophthalmic Nurs Technol 1992;11:71–6.

Mizushima Y , Ikoma T , Tanaka J , . Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Release 2006;110:260–5.

Guo D , Xu K , Zhao X , . Development of a strontium-containing hydroxyapatite bone cement. Biomaterials 2005;26:4073–83.

Giachelli CM . Inducers and inhibitors of biomineralization: lessons from pathological calcification. Orthod Craniofac Res 2005;8:229–31.

Parhami F , Bostrom K , Watson K , . Role of molecular regulation in vascular calcification. J Atherioscler Thromb 1996;3:90–4.

Schoenhagen P , Tuzcu EM . Coronary artery calcification and end-stage renal disease: vascular biology and clinical implications. Cleve Clin J Med 2002;69:12–20.

Demer LL . A skeleton in the atherosclerosis closet. Circulation 1995;92:2029–32.

Wexler L , Brundage B , Crouse J , . Coronary artery calcification; pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation 1996;94:1175–92.

Jono S , Shioi A , Ikari Y , . Vascular calcification in chronic kidney disease. J Bone Miner Metab 2006;24:176–81.

Blair B , Fabrizio M . Pharmacology for renal calculi. Exp Opin Pharmacother 2000;3:435–41.

Sohshang HL , Singh MA , Singh NG , . Biochemical and bacteriological study of urinary calculi. J Commun Dis 2000;32:216–21.

Driessens FC , Verbeeck RM , van Dijk JW . Plasma calcium difference between man and vertebrates. Comp Biochem Physiol A 1989;93:651–4.

Kajander EO , Ciftcioglu N. Nanobacteria : an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 1998;95:8274–9.

Miller VM , Rodgers G , Charlesworth JA , . Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 2004;287:1115–24.

Puskas LG , Tiszlavicz L , Razga Z , . Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 2005;56:233–45.

Ciftcioglu N , McKay DS , Kajander EO . Nanobacteria might be one of the potential agents in oral flora triggering peripheral arterial diseases. Circulation 2003;108:58–9.

Kajander EO , Liesi P , Ciftcioglu N . Do autonomously replicating sterile-filterable particles have an association with amyloid accumulation? Viruses and virus-like agents in disease [abstract] In: 2nd Karger Symposium, Basel, Switzerland. 1993 p. 41.

Ciftcioglu N , Björklund M , Willman K , . Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 1999;56:1893–8.

Ciftcioglu N , Haddad RS , Golden DC , . A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int 2005;67:483–91.

Ciftcioglu N . Kidney stone formation: an infectious disease? Jpn J Urol Sur 2002;15:228–32.

Kajander EO , Ciftcioglu N , Aho K , . Characteristics of nanobacteria and their possible role in stone formation. Urol Res 2003;31:47–54.

Shiekh FA , Khullar M , Singh SK . Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 2006;20:1–5.

Wen Y , Li YG , Yang ZL , . Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J 2005;118:421–4.

Wood HM , Shoskes DA . The role of nanobacteria in urologic disease. World J Urol 2006;24:51–4.

Shoskes DA , Thomas KD , Gomez E . Anti-nanobacterial therapy for men with chronic prostatitis/chronic pelvic pain syndrome and prostatic stones: preliminary experience. J Urol 2005;173:474–7.

Jelic TM , Malas AM , Groves SS , . Nanobacteria-caused mitral valve calciphylaxis in a man with diabetic renal failure. South Med J 2004;97:194–8.

Lopez-Brea M , Selgas R . Nanobacteria as a cause of renal diseases and vascular calcifying pathology in renal patients (“endovascular lithiasis”). Enferm Infecc Microbiol Clin 2000;18:491–2.

Hudelist G , Singer CF , Kubista E , . Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004;45:633–7.

Wainwright M . Nanobacteria and associated ‘elementary bodies’ in human disease and cancer. Microbiology 1999;145:2623–4.

Ciftcioglu N , Björklund M , Kajander EO . Stone formation and calcification by nanobacteria in human body. Proc SPIE 1998;3441:105–11.

Miller-Hjelle MA , Hjelle JT , Ciftcioglu N , . Nanobacteria: methods for growth and identification of this recently discovered calciferous agent. In: Olson WP , editor. Rapid analytical microbiology, The chemistry and physics of microbial identification. Surrey (UK): Davis Horwood International Publishing; 2003. p. 297–312.

Kajander EO , Kuronen I , Åkerman K , . Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth. Proc SPIE 1997;3111:420–8.

Ciftcioglu N , Miller-Hjelle MA , Hjelle JT , . Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 2002;46:2077–86.

Evan AP , Bledsoe SB , Connors BA , . Sequential analysis of kidney stone formation in the Aprt knockout mouse. Kidney Int 2001;60:910–23.

Naito Y , Ohtawara Y , Kageyama S , . Morphological analysis of renal cell culture models of calcium phosphate stone formation. Urol Res 1997;25:59–65.

Riccio V , Della Ragione F , Marrone G, et al. Cultures of human embryonic osteoblasts. A new in vitro model for biocompatibility studies. Clin Orthop Relat Res 1994;308:73–8.

Vali H , McKee MD , Ciftcioglu N , . Nanoforms: a new type of protein-associated mineralization. Geoch Cosmoch Acta 2001;65:63–74.

Becker W , Marxen J , Epple M , . Influence of microgravity on crystal formation in biomineralization. J Appl Physiol 2000;89:1601–7.

Whitson PA , Pietrzyk RA , Sams CF . Urine volume and its effects on renal stone risk in astronauts. Aviat Space Environ Med 2001;72:368–72.

Pak CY , Hill K , Cintron NM , . Assessing applicants to the NASA flight program for their renal stone-forming potential. Aviat Space Environ Med 1989;60:157–61.

McCarthy ID . Fluid shifts due to microgravity and their effects on bone: a review of current knowledge. Ann Biomed Eng 2005;33:95–103.

Maniloff J . Nannobacteria: size limits and evidence. Science 1996;273:924–30.

Glass JI , Assad-Garcia N , Alperovich N , . Essential genes of a minimal bacterium. Proc Natl Acad Sci U S A 2006;103:425–30.

Cisar JO , Xu DQ , Thompson J , . An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A 2000;97:11511–5.

Ciftcioglu N , Kajander EO . Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 1998;4:259–70.

Kajander EO . Calcific nano-particles; nature's “nanotechnology” as a cause of human disease [abstract] In: Nanotox 2006, January 29th-February 1st, Miami, FL.

Åkerman KK , Kuikka JT , Ciftcioglu N , . Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc SPIE 1997;3111:436–42.

Aho KM , Kajander EO , Ciftcioglu N . A novel multiplex-like ELISA test reveals that both Gla-clotting and anti-calcification proteins are present on calcifying nano-particles [abstract]. The ASCB 45th Annual Meeting, December 10-14, 2005, San Francisco.

Wahl C , Hess B . Kidney calculi-is nutrition a trigger or treatment? Ther Umsch 2000;57:138–45.

Trinchieri A , Castelnuovo C , Lizzano R , . Calcium stone disease: a multiform reality. Urol Res 2005;33:194–8.

Evan AP , Coe FL , Lingeman JE , . Insights on the pathology of kidney stone formation. Urol Res 2005;33:383–9.

Evan AP , Coe FL , Rittling SR , . Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 2005;68:145–54.

Khullar M , Sharma SK , Singh SK , . Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol Res 2004;32:190–5.

Drancourt M , Jacomo V , Lepidi H , . Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol 2003;41:368–72.

Burton EM , Hanna JD , Mercado-Deane MG. Nephrocalcinosis in a child with autosomal dominant polycystic kidney disease and a prolapsing ectopic ureterocele. Pediatr Radiol 1995;25:462–5.

Anim JT , Kehinde EO , Prasad A , . Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men. Int Urol Nephrol 2006;38:27–32.

Muezzinoglu B , Gurbuz Y . Stromal microcalcification in prostate. Malays J Pathol 2001;23:31–3.

Geramoutsos I , Gyftopoulos K , Perimenis P , . Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004;45:333–7.

Torres Ramirez C , Aguilar Ruiz J , Zuluaga Gomez A , . Ultrastructure of primary or endogenous prostatic calculi. Scanning electron microscopic study. Arch Esp Urol 1981;34:13–22.

Maniscalco BS , Taylor KA . Calcification in coronary artery disease can be reversed by EDTA-tetracycline long-term chemotherapy. Pathophysiology 2004;11:95–101.

Zhu J , Kajander EO , Katz RJ , . Increased serum levels of nanobacteria antibodies are associated with high coronary calcification score. Supp Circ 2004;110:627.

Ertas F , Hasan T , Akan O , . Anti-nanobacterial antibody titer is an independent risk factor for coronary artery calcification [abstract]. American College of Cardiology 55th Annual Scientific Session Exposition. March 11–14, Atlanta.

Sedivy R , Battistutti WB . Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 2003;111:951–4.

Sommer AP , Pavlath AE . Primordial proteins and HIV. J Proteome Res 2005;4:633–6.

Pretorius AM , Sommer AP , Aho KM , . HIV and nanobacteria. HIV Med 2004;5:391–3.

Ciftcioglu N , Ciftcioglu V , Vali H , . Sedimentary rocks in our mouth: dental pulp stones made by nanobacteria. Proc SPIE 1998;3441:130–5.

Sommer AP . Could reduced bone mineral densities in HIV be caused by nanobacteria? J Proteome Res 2004;3:670–2.

Zhou HD , Li GY , Yang YX , . Intracellular co-localization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 2006;43(11):1864–71.

Ciftcioglu N , Kuronen I , Åkerman K , . A new potential threat in antigen and antibody products: nanobacteria. In: Brown F , Burton D , Doherty P , , EDITORS. Vaccines 97 Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997. P. 99–103.

Kajander EO , Aho K , Ciftcioglu N . Detection of nanobacteria in viral vaccines. 101th General Meeting of American Society for Microbiology in May 20-24, 2001 in Orlando, USA. Paper Y-3.